— Know what they know.
Not Investment Advice
Also trades as: NOTVQ (OTC) · $vol 0M

NOTV NASDAQ

Inotiv, Inc.
1W: -67.3% 1M: -88.4% 3M: -90.0% YTD: -93.3% 1Y: -98.5% 3Y: -99.3% 5Y: -99.9%
$0.08
Last traded 2026-06-15 — delisted
NASDAQ · Healthcare · Medical - Diagnostics & Research · $2.8M mcap · 32M float · 61.32% daily turnover · Short 44% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.8M
52W Range0.0167-2.44
Volume16,061,274
Avg Volume19,818,502
Beta4.08
Dividend
Analyst Ratings
2 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEORobert W. Leasure
Employees2,027
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date1997-11-25
Websiteinotiv.com
2701 Kent Avenue
West Lafayette, IN 47906
US
765 463 4527
About Inotiv, Inc.

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

Recent Insider Trades

NameTypeSharesPriceDate
Taylor Beth A. F-InKind 5,864 $0.02 2026-06-18
Sagartz John E F-InKind 6,071 $0.02 2026-06-18
Hardy Adrian F-InKind 5,371 $0.02 2026-06-18
Freeman Jeffrey Bren F-InKind 5,855 $0.02 2026-06-18
Castetter Andrea F-InKind 5,800 $0.02 2026-06-18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms